Zheng Hua Ren
Directeur/Membre du Conseil chez Hangzhou Shangjian Biotechnology Co., Ltd.
Profil
Zheng Hua Ren has worked as a Director at Hangzhou Shangjian Biotechnology Co., Ltd.
and as a Partner at ADDOR Capital Management Co. Ltd.
Postes actifs de Zheng Hua Ren
| Sociétés | Poste | Début |
|---|---|---|
ADDOR Capital Management Co. Ltd.
 ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Private Equity Investor | - |
Hangzhou Shangjian Biotechnology Co., Ltd.
 Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
ADDOR Capital Management Co. Ltd.
ADDOR Capital Management Co. Ltd. Investment ManagersFinance ADDOR Capital Management Co. Ltd is founded in 2010 and headquartered in Nanjing, China. | Finance |
Hangzhou Shangjian Biotechnology Co., Ltd.
Hangzhou Shangjian Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Shangjian Biotechnology Co., Ltd. is a company that develops, manufactures, and markets therapeutic antibody drugs and antibodies. The company is based in Hangzhou, China. The Chinese company was founded in 2015 by Ming Lu, who has been the CEO since 2015. | Health Technology |
